ANTI-TNF THERAPY RESPONSE IS ASSOCIATED WITH LOWER MUCOSAL EXPRESSION OF INFLAMMATORY CYTOKINES BEFORE THERAPY START IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

(1) Medicine, Internal Medicine And Clinical Nutrition, Gothenburg, Sweden

(2) Biomedicine, Immunology & Microbiology, Gothenburg, Sweden

(3) Södra Älvsborgs Sjukhus, Borås, Sweden

(4) Kärnsjukhuset, Skövde, Sweden



This item was part of UEG Week 2014

This item can be cited as: United European Gastroenterology Journal; 2014: 2 (Supplement 1)

You may be interested in:

THE PATHOPHYSIOLOGY AND SEVERITY OF SYMPTOMS IN IBS PATIENTS ARE NOT ASSOCIATED WITH MUCOSAL IMMUNE ACTIVITY AS DETERMINED BY FECAL CALPROTECTIN
English, Irritable Bowel Syndrome, Brain-gut and gut-brain axes, neuro-hormonal, neuralimmune and visceral sensitivity, Abstract, 2013
Immunity and barrier function
English, Presentation, 2015, Disease Mechanisms, Histopathology, Immunology, Neurogastroenterology & Motility, Paediatrics, Primary Care, Radiology & Imaging, Gut Microbiota

Categorisation:

  • Format
    • Abstract
  • Year
    • 2014